(based on the PCR-positive stx 2 gene) was detected from the same sample. A presumptive STEC strain was subsequently isolated. Both isolates were sent for confirmation and further typing to the Bacteriology Unit, National Institute for Health and Welfare, in Helsinki. The first isolate (FE109024) was confirmed as S. sonnei by matching of its biochemical profile to that of the reference strain ATCC 25931 (http://www.atcc.org/Products/All/25931.aspx; online Technical Appendix Table, http://wwwnc.cdc.gov/ EID/article/21/5/14-0621-Techapp1.pdf) and agglutination by antiserum to S. sonnei (Denka Seiken, Tokyo, Japan). The agglutination by S. sonnei phase I antiserum indicated the smooth form of lipopolysaccharide. Atypical for S. sonnei, the isolate did not ferment mannitol (7) . The isolate carried the genes encoding invasion plasmid antigen H, the invasion-associated locus, and invasion gene transcription regulator invE. The second isolate (FE109046) was initially sent to the National Institute for Health and Welfare as an STEC. However, FE109046 showed biochemical reactions in tubes and when using API 20E (bioMérieux, Durham, NC, USA) that were identical to reactions for isolate FE109024 after an overnight and 3-day incubation (online Technical Appendix Table) . Both isolates were nonmotile. FE109046 also agglutinated by S. sonnei polyvalent antiserum but was negative for S. sonnei phase I antiserum and positive for phase II antiserum, indicating the rough form of lipopolysaccharide. In contrast to FE109024, isolate FE109046 lacked the Shigella/enteroinvasive E. coli-specific invE gene but harbored the STEC-specific stx 2 gene. Neither isolate carried other STEC-associated genes. Subtyping of the stx 2 gene of isolate FE109046 was performed according to the published protocol (8); the isolate was confirmed to be subtype stx 2a .
Genomic comparison of the 2 isolates was performed by using pulsed-field gel electrophoresis according to the standard protocol. The isolates showed 96% similarity. A 3-fragment difference suggests that 1 isolate was a variant of the other (Figure) ; the variant may have arisen through lysogenization with the phage.
The Shiga toxin subtype stx 2a identified in isolate FE109046 is linked to severe human disease, including HUS (3). The role of Stx in shigellosis is unclear. Stx is not essential for cell invasion or lysis (9) . In the previously reported case of stx 1 -positive S. sonnei infection, the patient's symptoms were not severe, and diarrhea lasted 7 days (6) .
Shigella spp. can harbor virulence genes found in E. coli because both are genetically defined as members of the same species (10) . The stx 2 -positive S. sonnei may have emerged in the patient initially infected with a mannitol-negative S. sonnei that was subsequently lysogenized by transduction from a STEC co-infection or by a free stx 2 phage. S. sonnei isolates are not routinely examined for the production of Stx or stx genes in clinical laboratories, so the properties associated with STEC in S. sonnei isolates from patients remain undetected. S. sonnei with stx 2a may have potential to cause severe disease, especially in children. This novel and remarkable virulence characteristic in Shigella spp. would affect diagnostics, infection control, and prevention.
Figure.
UPGMA dendrogram of XbaI restriction patterns of 2 Shigella sonnei isolates from a patient from Finland who became ill during a visit to Morocco. Genomic comparison of the 2 isolates was performed by using pulsed-field gel electrophoresis according to the standard protocol. The isolates showed 96% similarity, and a 3-fragment difference suggests that 1 isolate was a variant of the other. Scale bar represents % similarity. ial, invasion-associated locus; ipaH, invasion plasmid antigen H; invE, invasion gene transcription regulator invE; stx 2 , Shiga toxin 2.
